CIK 0000842023 · Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411427402
- Phone
- 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-05-29 | WIENS HAROLD J Director | Option exercise · Stock Option (Right to Buy) | −3,985 | 0 | ||
| 2020-05-29 | Eansor Norman David President-Protein Sciences | Option exercise | +7,909 | $108.49 | $858K | 7,909 |
| 2020-05-29 | Eansor Norman David President-Protein Sciences | Sale | −1,700 | $260.83 | $443K | 6,209 |
| 2020-05-29 | Eansor Norman David President-Protein Sciences | Sale | −3,400 | $261.74 | $890K | 2,809 |
| 2020-05-29 | Eansor Norman David President-Protein Sciences | Sale | −2,100 | $262.68 | $552K | 709 |
| 2020-05-29 | Eansor Norman David President-Protein Sciences | Sale | −709 | $264.01 | $187K | 0 |
| 2020-05-29 | Eansor Norman David President-Protein Sciences | Option exercise · Stock Options (Right to Buy) | −7,909 | 0 | ||
| 2020-05-28 | Furlow Brenda S. SVP - General Counsel | Option exercise | +5,995 | $108.49 | $650K | 8,706 |
| 2020-05-28 | Furlow Brenda S. SVP - General Counsel | Option exercise | +1,600 | $94.35 | $151K | 10,306 |
| 2020-05-28 | Furlow Brenda S. SVP - General Counsel | Sale | −2,195 | $259.72 | $570K | 8,111 |
| 2020-05-28 | Furlow Brenda S. SVP - General Counsel | Sale | −3,800 | $260.38 | $989K | 4,311 |
| 2020-05-28 | Furlow Brenda S. SVP - General Counsel | Option exercise · Stock Options (Right to Buy) | −1,600 | 0 | ||
| 2020-05-28 | Furlow Brenda S. SVP - General Counsel | Option exercise · Stock Options (Right to Buy) | −5,995 | 10,000 | ||
| 2020-05-28 | Eansor Norman David President-Protein Sciences | Option exercise | +3,448 | $108.49 | $374K | 3,448 |
| 2020-05-28 | Eansor Norman David President-Protein Sciences | Sale | −3,448 | $260.19 | $897K | 0 |
| 2020-05-28 | Eansor Norman David President-Protein Sciences | Option exercise · Stock Options (Right to Buy) | −3,448 | 7,909 | ||
| 2020-05-26 | Kummeth Charles R. Chief Executive Officer | Option exercise | +21,159 | $86.25 | $1.8M | 151,148 |
| 2020-05-26 | Kummeth Charles R. Chief Executive Officer | Shares withheld for taxes | −13,018 | $266.40 | $3.5M | 138,130 |
| 2020-05-26 | Kummeth Charles R. Chief Executive Officer | Option exercise · Stock Options (Right to Buy) | −21,159 | 25,157 | ||
| 2020-05-22 | WIENS HAROLD J Director | Gift | −378 | 4,843 |
Page 44 of 53 · 1,043 trades